2023
Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia
Setia O, Lee S, Dardik A. Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia. Advances In Wound Care 2023, 13: 253-279. PMID: 37002893, PMCID: PMC11305013, DOI: 10.1089/wound.2022.0114.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChronic limb threatening ischemiaPeripheral arterial diseaseSevere peripheral arterial diseaseLimb threatening ischemiaClinical trialsCell therapyStem cell therapyIschemic limbsFeasible therapeutic alternativePromising treatment optionPre-clinical studiesCell deliveryPAD patientsArterial diseaseClinical benefitTreatment optionsSurgical methodsTherapeutic alternativeBest modalityHigh riskLimb lossSevere formTherapeutic benefitPatientsTherapy
2020
Vascular Malformations of the Brain and Spine
Matouk C, Cord B. Vascular Malformations of the Brain and Spine. 2020, 177-191. DOI: 10.1007/978-3-030-52552-1_14.Peer-Reviewed Original ResearchVascular malformationsCommon vascular lesionsDiagnostic imaging modalitiesStroke riskIntracranial hemorrhageVascular neurologistsTreatment optionsVascular lesionsBest modalityInterventional radiologistsVascular neurosurgeonsNatural historyImaging modalitiesMalformationsModalitiesHemorrhageNeurologistsLesionsDiagnosisPathologyBrainNeurosurgeonsSpine
2016
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance
Palazzuoli A, Testani JM, Ruocco G, Pellegrini M, Ronco C, Nuti R. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance. International Journal Of Cardiology 2016, 224: 213-219. PMID: 27657476, DOI: 10.1016/j.ijcard.2016.09.005.Peer-Reviewed Original ResearchConceptsLower diuretic efficiencyChronic kidney diseaseDiuretic efficiencyAdverse eventsDose administrationAcute decompensated heart failureDecompensated heart failureAdverse event ratesDiuretic doseWRF occurrenceRenal dysfunctionClinical characteristicsRenal functionHeart failureHD patientsMultivariable analysisClinical statusPrognostic significanceAdverse outcomesContinuous administrationKidney diseaseDE patientsLD patientsBest modalityPatientsVascular Malformations
Amin H, Schindler J. Vascular Malformations. 2016, 135-146. DOI: 10.1007/978-3-319-39605-7_14.Peer-Reviewed Original ResearchVascular malformationsCommon vascular lesionsDiagnostic imaging modalitiesStroke riskIntracranial hemorrhageVascular neurologistsTreatment optionsVascular lesionsBest modalityInterventional radiologistsVascular neurosurgeonsNatural historyImaging modalitiesMalformationsModalitiesHemorrhageNeurologistsLesionsDiagnosisPathologyNeurosurgeons
2013
Laparoscopic staging and surgical treatment of pancreatic cancer
Muniraj T, Barve P. Laparoscopic staging and surgical treatment of pancreatic cancer. North American Journal Of Medical Sciences 2013, 5: 1-9. PMID: 23378948, PMCID: PMC3560131, DOI: 10.4103/1947-2714.106183.Peer-Reviewed Original ResearchPancreatic cancerSurgical treatmentPortal vein resectionPercentage of patientsFourth leading causeStandard of careComputed tomography scanResectable stageExtended lymphadenectomyLaparoscopic stagingVein resectionRegional lymphadenectomyArterial reconstructionCancer deathCommon cancerLeading causeTomography scanBest modalityLaparoscopic ultrasoundCancerMultiple studiesLymphadenectomyStagingTreatmentPancreaticoduodenectomy
2012
18F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[18F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography
Zhang Y, Dasilva JN, Hadizad T, Thorn S, Kuraitis D, Renaud JM, Ahmadi A, Kordos M, Dekemp RA, Beanlands RS, Suuronen EJ, Ruel M. 18F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[18F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography. Cell Transplantation 2012, 21: 1821-1835. PMID: 22469629, DOI: 10.3727/096368911x637416.Peer-Reviewed Original ResearchConceptsCirculating Progenitor CellsPositron emission tomographyEmission tomographyCell therapyPET imagingCell transplantation groupProgenitor cellsCoronary artery ligationRat myocardial infarction modelInfarct border zoneHeart tissue sectionsMyocardial infarction modelBorder zoneCardiac cell therapyTransplantation groupIschemic/Artery ligationH posttransplantationBest modalityHuman progenitor cellsIntramyocardial injectionH postinjectionInjection siteTissue biodistributionInfarction model
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply